Paragon Genomics, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 20, 2026The maintenance fee for Methods and compositions for amplifying DNA and generating DNA sequencing results from target-enriched DNA molecules (US 11,680,293) comes due Dec 20, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due Mar 24, 2027The maintenance fee for Methods and Compositions for Reducing Non-Specific Amplification Products (US 10,421,993) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,464,318 | Methods and Compositions for Reducing Non-Specific Amplification Products In force · High confidence | In force | High confidence | |
| US 10,421,993 | Methods and Compositions for Reducing Non-Specific Amplification Products In force · High confidence | In force | High confidence | |
| US 10,100,358 | Methods and Compositions for Reducing Redundant Molecular Barcodes Created in Primer Extension Reactions In force · High confidence | In force | High confidence | |
| US 10,941,453 | High throughput detection of pathogen RNA in clinical specimens In force · From the USPTO record | In force | From the USPTO record | |
| US 11,680,293 | Methods and compositions for amplifying DNA and generating DNA sequencing results from target-enriched DNA molecules In force · From the USPTO record | In force | From the USPTO record | |
| US 12,091,715 | Methods and compositions for reducing base errors of massive parallel sequencing using triseq sequencing In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 no status recorded